Theriva Biologics, Inc. (TOVX)

Theriva Biologics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	16.41	23.18	41.79	67.33	6.23	15.05
Cash & Short-Term Investments	16.41	23.18	41.79	67.33	6.23	15.05
Cash Growth	-47.34%	-44.53%	-37.93%	981.18%	-58.61%	-47.97%
Other Receivables	1.83	1.94	0.23	-	0.47	0
Receivables	1.83	1.94	0.23	-	0.47	0
Prepaid Expenses	1.29	1.17	1.21	1.08	0.77	1.33
Other Current Assets	-	1.12	2.29	0.46	0.47	0.05
Total Current Assets	19.53	27.4	45.52	68.86	7.93	16.43
Property, Plant & Equipment	1.74	2.18	1.54	1.48	0.45	0.79
Goodwill	-	5.7	5.53	-	-	-
Long-Term Deferred Charges	18.65	19.76	19.15	-	-	-
Other Long-Term Assets	0.18	0.18	0.12	0.02	0.02	0.02
Total Assets	40.11	55.22	71.86	70.37	8.41	17.24
Accounts Payable	0.76	0.77	0.92	0.52	0.89	2.32
Accrued Expenses	5.05	4.51	2.9	2.91	1.79	2.71
Current Portion of Long-Term Debt	0.07	0.06	0.06	-	-	-
Current Portion of Leases	0.54	0.49	0.22	0.12	0.29	0.25
Other Current Liabilities	0.92	0.91	2.97	-	-	-
Total Current Liabilities	7.32	6.74	7.06	3.55	2.97	5.28
Long-Term Debt	0.1	0.16	0.22	-	-	-
Long-Term Leases	1.04	1.44	1.19	1.4	0.19	0.47
Long-Term Deferred Tax Liabilities	-	-	1.62	-	-	-
Other Long-Term Liabilities	7.02	7.18	7.21	-	-	-
Total Liabilities	15.47	15.52	17.3	4.96	3.15	5.75
Common Stock	0	0.02	0.02	0.01	0.03	0.02
Additional Paid-In Capital	355.33	346.52	343.75	336.68	240.82	232.58
Retained Earnings	-330.53	-309.32	-290.97	-271.28	-248.09	-235.54
Treasury Stock	-0.29	-0.29	-0.29	-	-	-
Comprehensive Income & Other	0.11	0.03	-0.68	-	-	-
Total Common Equity	24.64	36.96	51.83	65.41	-7.24	-2.94
Minority Interest	-	-	-	-	-2.77	-2.88
Shareholders' Equity	24.64	39.7	54.56	65.41	5.26	11.49
Total Liabilities & Equity	40.11	55.22	71.86	70.37	8.41	17.24
Total Debt	1.74	2.15	1.68	1.53	0.47	0.72
Net Cash (Debt)	14.67	21.02	40.11	65.8	5.75	14.32
Net Cash Growth	-49.31%	-47.58%	-39.05%	1043.52%	-59.83%	-50.47%
Net Cash Per Share	17.88	32.63	65.41	134.97	75.67	217.83
Filing Date Shares Outstanding	2.62	0.69	0.6	0.63	0.52	0.07
Total Common Shares Outstanding	2.62	0.69	0.6	0.53	0.12	0.07
Working Capital	12.21	20.67	38.46	65.3	4.97	11.15
Book Value Per Share	9.41	53.89	85.67	123.84	-61.91	-43.73
Tangible Book Value	24.64	31.26	46.31	65.41	-7.24	-2.94
Tangible Book Value Per Share	9.41	45.58	76.54	123.84	-61.91	-43.73
Machinery	-	0.9	0.9	0.83	0.81	0.8
Leasehold Improvements	-	0.09	0.09	0.09	0.44	0.44

Source: S&P Capital IQ. Standard template. Financial Sources.